John A. Johnson, MD, MBA: Type 2 diabetes has become an epidemic in the United States, and at WellCare, we consider it one of our top priorities because most of the members we serve have type 1 or type 2 diabetes. We rank that very high in our priority along with hypertension, hyperlipidemia, [and] heart and cardiovascular diseases such as heart failure, myocardial infarction, and stroke. Diabetes is a risk factor for all of the other types of cardiovascular diseases, [and therefore] all of our programs are designed to eradicate or treat diabetes as best as possible.
At WellCare, we have what’s called our case and disease management programs. These are programs that partner with the providers and patients (or members we serve) to help improve the outcomes of [a patient’s] disease. From a cost-avoidance perspective, we try to enhance the quality of services that our members receive by providing wraparound services or support. For example, with diabetes disease management, this involves a nurse or social worker identifying patient-centered barriers to care—whether access, transportation, or care gaps—and [working to figure out] how we can help that patient, or member of ours, get the services that they need and prioritize their care from their perspective.
At WellCare, this is a very big priority [and a reason why] all of our programs are interwoven. For example, we also have a program called Advocacy. Our Advocacy program identifies social-economic barriers that our diabetics may have in their communities—whether they live in a food desert where they don’t have access to healthy nutrition or they lack an ability to participate in an exercise program, carb counting, or meal planning. So, our Advocacy program identifies community partners that we can work with to enhance those services in a collaborative way.
Again, diabetes is at the core of what we do, and is the disease that we manage. Our belief is that if we can connect those patients (our members) to these services, then downstream, we can improve quality, improve clinical outcomes, and enhance the member experience.
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
October 24th 2024The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More